USD 2.44 billion growth in travel vaccine market size with 42% contribution from North America

New York, August 22, 2022 /PRNewswire/ — The latest market analysis report titled Travel vaccine market By Disease Type and Geography – Forecast and Analysis 2022-2026 has just been added to Technavio’s catalog. Report analysts have classified the global travel vaccine market as a segment of the global pharmaceutical market. Our report provides detailed information on the value chain analysis for the travel vaccine market, which vendors can leverage to gain a competitive advantage over the forecast period. The data available in our value chain analysis section helps vendors drive costs and enhance customer services during the forecast period. One of the major factors driving the growth of the global travel vaccine market is the increase in global travel and migration. Additionally, changes in the demographic profile of travelers globally are among the key travel vaccine market trends that are expected to positively impact the industry over the forecast period. However, lack of coverage of travel vaccines in many health plans is expected to limit the market growth during the forecast period.

The latest market research report titled Travel Vaccine Market by Disease Type and Geography – Forecast and Analysis 2022-2026 has been announced by Technavio which has been proudly partnering with Fortune 500 companies for over 16 years.

For market scope, value chain analysis, and key market dynamics, Read a free sample

Travel Vaccine Market Segmentation Highlights

For more segment-based insights and regional opportunities, Request for a sample report

  • The travel vaccine market is fragmented and vendors are using growth strategies such as investing in R&D to compete in the market. Travel Vaccines Market Forecast Report provides in-depth insights into key vendor profiles. The profiles include information about the production, stability, and prospects of the leading companies.

  • Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc. , Mitsubishi Chemical Holdings Corporation, Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE Some are major market participants.

  • To make the most of opportunities, marketers should focus more on growth prospects in fast-growing segments while maintaining their positions in slow-growing segments.

  • Vendors are offering a wide range of offerings to gain a competitive edge in the market. For example, CSL Ltd. offers the broadest range of influenza vaccines and a variety of vaccines and specialty drugs that meet unique, local public health needs. Bharat Biotech Limited offers travel vaccines such as BioHib, a lyophilized vaccine based on the Indian strain used for development.

  • Backed with competitive intelligence and benchmarking, our research reports on the travel vaccine market are designed to provide entry support, customer profiling, and M&As as well as go-to-market strategy support.

More vendor offerings and their strategic initiatives are available here PDF sample report

Travel Vaccine Market Scope

Technavio presents a comprehensive picture of the market through the study, synthesis, and aggregation of data from multiple sources. Our travel vaccination market report covers the following areas:

Travel vaccine market highlights

  • CAGR of the market during the forecast period 2022-2026

  • Detailed information on factors contributing to travel vaccine market growth over the next five years

  • An estimate of the travel vaccine market size and its contribution to the parent market

  • Predictions on upcoming trends and changes in consumer behavior

  • Growth of the travel vaccine market

  • Analysis of market competitive landscape and detailed information on vendors

  • A detailed description of factors challenging the growth of Travel Vaccine market vendors

Related reports:

The vaccine market By Type and Geography – Forecast and Analysis 2022-2026

Human combination vaccine market By Type and Geography – Forecast and Analysis 2021-2025

Therapeutic Vaccines Market By Type and Geography – Forecast and Analysis 2020-2024

Foot and mouth disease vaccine market By Product and Geography – Forecast and Analysis 2021-2025

Travel Vaccine Market Scope

Report coverage

Details

Page number

120

base year

2021

Forecast period

2022-2026

Growth rate and CAGR

Accelerated at a CAGR of 8.59%

Market Growth 2022-2026

$2.44 billion

Market structure

fragmented

Annual Growth (%)

7.85

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Demonstrating market contribution

North America 42%

Major consumer countries

US, Germany, UK, Japan and China

Competitive landscape

Leading companies, competitive strategies, consumer engagement range

Companies profile

Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc. , Mitsubishi Chemical Holdings Corporation, Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE

Market dynamics

Parent market analysis, market growth inducers and restraints, fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, and market situation analysis for the forecast period.

Custom range

If our report does not contain the data you are looking for, you can contact our analysts and customize the sections.

Table of Contents:

1 Executive Summary

2 Market scenario

3 Market size

4 Five Forces Analysis

5 Market segmentation by disease type

6 Customer scenario

7 Geographical landscape

8 Drivers, Challenges, and Trends

9 vendor scenario

10 Vendor Analysis

11 Appendix

about us

Technavio is a leading global technology research and consulting company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With more than 500 specialized analysts, Technavio’s report library contains more than 17,000 reports and calculations, covering 800 technologies spanning 50 countries. Their client base includes enterprises of all sizes, including over 100 Fortune 500 companies. This growing customer base relies on Technavio’s extensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions in changing market scenarios.

Get in touch

Technavio research
Jesse Maida
Media and Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
email: [email protected]
Website: www.technavio.com/

Technavio (PRNewsfoto/Technavio)

Technavio (PRNewsfoto/Technavio)

the season

the season

View original content to download multimedia: https://www.prnewswire.com/news-releases/usd-2-44-billion-growth-in-travel-vaccines-market-size-with-42-of-the-contribution -from-north-america—technavio-301609618.html

Source Technovio

Leave a Comment

Your email address will not be published.